SCHEMBL18436648

SCHEMBL18436648

C=C1NC(=O)c2c(cccc2-c2ccccc2)N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 2/20 0.41
▸ MAOA P21397 3/20 0.39
▸ MAOB P27338 3/20 0.39
▸ LRRK2 Q5S007 2/20 0.39
▸ PDGFRA P16234 1/20 0.39
▸ FER P16591 1/20 0.39
▸ LTK P29376 1/20 0.39
▸ CDK8 P49336 1/20 0.39
▸ ACVR1 Q04771 1/20 0.39
▸ DYRK1B Q9Y463 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ PARP10 Q53GL7 1/20 0.38
▸ PARP11 Q9NR21 1/20 0.38
▸ HDAC4 P56524 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ RET P07949 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9110123 0.77 MAOA (0.57) FLT3MAOAMAOBLRRK2PDGFRA
SCHEMBL5703588 0.76 LRRK2 (0.65) MAOAMAOBLRRK2PDGFRAFER
SCHEMBL135332 0.74 GSK3B (0.56) LRRK2PDGFRAFERLTKCDK8
SCHEMBL29032840 0.73 GSK3B (0.54) LRRK2PDGFRAFERLTKCDK8
Ammonia Solution, Strong SCHEMBL28821133 0.73 GSK3B (0.54) LRRK2PDGFRAFERLTKCDK8
SCHEMBL9353414 0.71 LRRK2 (0.47) FLT3MAOAMAOBLRRK2PDGFRA
SCHEMBL29589906 0.70 HDAC4 (0.41) FLT3LMNAMAPTPARP10PARP11
SCHEMBL3671263 0.70 HNF4A (0.42) FLT3LMNAMAPTPARP10PARP11
SCHEMBL52297 0.70 HDAC4 (0.41) FLT3LMNAMAPTPARP10PARP11
SCHEMBL5616554 0.68 GSK3B (0.52) LRRK2PDGFRAFERLTKCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3575288-A1 QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS Bristol-Myers Squibb Company (US) 2019-12-04 — — EP disclosed
EP-3124475-A1 QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS Bristol-Myers Squibb Company (US) 2017-02-01 — — EP disclosed
Send feedback